STEAP, a prostate tumor antigen, is a target of human CD8⁺ T cells

By Alves Pedro   Faure Olivier   Graff-Dubois Stéphanie   Cornet Sebastien   Bolonakis Irena   Gross David-Alexandre   Miconnet Isabelle   Chouaib Salem   Fizazi Karim   Soria Jean   Lemonnier François   Kosmatopoulos Kostas  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1515-1523

Springer Publishing Company

Access to resources Recommend Favorite

The properties of human CD40-activated B cells as antigen-presenting cells are not affected by PGE2

By            

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1061-1065

Spandidos Publications

Access to resources Recommend Favorite

Enhanced central memory cluster of differentiation 8+ and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 515-521

Science Publishers

Access to resources Recommend Favorite

In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells

By Lu Xiao-ling  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 629-638

Springer Publishing Company

Access to resources Recommend Favorite

In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells

By Lu Xiao-ling  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 639-639

Springer Publishing Company

Access to resources Recommend Favorite